Taligen raises $10 million

Taligen Therapeutics Inc. (Cambridge, Mass.) raised $10 million in a fourth tranche of a $65 million series B round. The series B round was secured in February 2008, and with this tranche the company has closed on $36 million. Existing investors Clarus; Alta Partners; Sanderling; and High Country Venture participated. ...